|
|
Volumn 23, Issue 9, 2005, Pages 1025-
|
|
King in the kingdom of uncertainty
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
IMMUNOGLOBULIN G;
INFLIXIMAB;
MONOCLONAL ANTIBODY;
NATALIZUMAB;
PALIVIZUMAB;
RITUXIMAB;
TRASTUZUMAB;
ALGORITHM;
AUTOIMMUNE DISEASE;
CANCER;
CELL MIGRATION;
COST BENEFIT ANALYSIS;
DRUG COST;
DRUG INDUSTRY;
EDITORIAL;
IMMUNOGENICITY;
MULTIPLE SCLEROSIS;
PRIORITY JOURNAL;
VIRUS INFECTION;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIBODY SPECIFICITY;
CHEMISTRY, PHARMACEUTICAL;
CLINICAL TRIALS;
HUMANS;
|
|
EID: 27144556618
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0905-1025 Document Type: Editorial |
|
Times cited : (3)
|
|
References (0)
|